WHY IT MATTERS: If you are a parent or caregiver, this research suggests that community-wide shifts in cannabis availability and cultural acceptance directly influence the likelihood that your teen encounters heavier use patterns, making household conversations about cannabis more important than ever. CLINICAL OVERVIEW: New research from Sweden suggests that adolescent cannabis use follows the same population-level consumption patterns as alcohol, meaning that when overall use rises in a population, heavy use rises disproportionately among the most vulnerable youth. This finding has important clinical implications because it reinforces that broad prevention strategies targeting overall youth substance exposure, rather than solely focusing on individual high-risk teens, may be the most effective approach to reducing problematic cannabis use in adolescents.
ARTELO BIOSCIENCES, INC. SEC 10-K Report – TradingView
WHY IT MATTERS: If endocannabinoid-targeted pharmaceuticals like these gain FDA approval, patients dealing with cancer-related weight loss and chemotherapy nerve pain could eventually have insurance-covered, standardized treatment options that work through the same system cannabis does. CLINICAL OVERVIEW: Artelo Biosciences is advancing pharmaceutical candidates that target the endocannabinoid system, including ART27.13 for cancer-related anorexia and ART26.12 for chemotherapy-induced peripheral neuropathy. These drug development programs represent a growing trend of biotech companies working to create FDA-approvable medications that modulate endocannabinoid pathways rather than relying solely on plant-derived cannabinoids.
Medicare may soon cover certain cannabis medications for seniors – MSU Denver RED
WHY IT MATTERS: If Medicare begins covering cannabis-based medications, seniors who currently spend hundreds of dollars monthly out of pocket on cannabinoid therapies could see significant cost relief and improved access to physician-supervised treatment plans. CLINICAL OVERVIEW: The possibility of Medicare covering certain cannabis-based medications represents a significant shift in how the federal government treats cannabinoid therapeutics for older adults. From a clinical standpoint, this could dramatically improve access for seniors who currently pay entirely out of pocket for cannabis medicines, often on fixed incomes, while simultaneously catalyzing the rigorous research needed to establish evidence-based dosing protocols and safety profiles for this population.
420 with CNW — Study Links Psychiatric Disorders to Adolescent Cannabis Use
WHY IT MATTERS: If you are a parent or caregiver of a teenager, this research underscores why adolescent cannabis use should only occur under direct medical supervision with careful psychiatric screening, and why recreational or unsupervised use during brain development carries meaningful risk. CLINICAL OVERVIEW: Research continues to explore the association between adolescent cannabis use and the development of psychiatric disorders, including psychosis, depression, and bipolar spectrum conditions. While these correlational findings are important to acknowledge, clinicians must also consider confounding variables such as pre-existing mental health conditions, adverse childhood experiences, genetic predisposition, and the role of self-medication that may drive early cannabis use in vulnerable youth.
Indiana hemp drug ban, early voting restrictions die at deadline
WHY IT MATTERS: If you are an Indiana resident currently using hemp-derived THC products for symptom management, your access remains unchanged for now, but you should still exercise caution because these products remain largely unregulated for potency, purity, and accurate labeling. CLINICAL OVERVIEW: Indiana’s proposed ban on intoxicating hemp-derived THC products failed to advance before a legislative deadline, leaving the current market for these products intact for now. This outcome means that consumers in Indiana will continue to have access to hemp-derived THC products that exist in a regulatory gray area under the 2018 Farm Bill, though the lack of comprehensive regulation also means product safety and labeling standards remain inconsistent.
Florida Lawmakers Vote To Slash Medical Marijuana Fees For Military Veterans
WHY IT MATTERS: If you are a military veteran in Florida seeking a medical marijuana card, this bill could meaningfully reduce your out-of-pocket registration costs and make it easier to start or maintain your cannabis treatment plan. CLINICAL OVERVIEW: Florida is advancing legislation to reduce the cost of medical marijuana registry identification cards for military veterans, addressing a longstanding financial barrier that has kept some veterans from accessing state-legal cannabis therapy. Veterans disproportionately suffer from chronic pain, PTSD, traumatic brain injury, and sleep disorders, all conditions where cannabis medicine has shown meaningful clinical benefit.
A new way to study how cannabis use impacts safe driving | EurekAlert!
WHY IT MATTERS: If you use cannabis medicinally and drive, better research into impairment testing could eventually replace unreliable THC blood level thresholds with assessments that more fairly and accurately reflect whether you are actually safe behind the wheel. CLINICAL OVERVIEW: As cannabis legalization continues to expand across the United States, research into how cannabis use affects driving performance remains critically underdeveloped, creating a significant gap between policy and patient safety evidence. New approaches to studying cannabis-impaired driving are essential because unlike alcohol, THC affects psychomotor function in highly variable ways depending on tolerance, dosing method, cannabinoid profile, and individual metabolism.
Bill to protect Nebraska physicians recommending medical cannabis advances to floor
WHY IT MATTERS: If you are a Nebraska patient seeking medical cannabis, this bill could expand the number of physicians willing to recommend it, reducing wait times and improving access to qualified clinical guidance. CLINICAL OVERVIEW: Nebraska is advancing legislation to protect physicians who recommend medical cannabis from facing disciplinary action by state medical boards, a critical step in normalizing physician participation in cannabis care programs. Physician protection laws are foundational to functional medical cannabis programs because without them, doctors face career risk that chills participation and limits patient access.
Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure
WHY IT MATTERS: If you are pregnant or planning to become pregnant and currently use cannabis, this research underscores why having an honest, judgment-free conversation with your physician about timing, risks, and alternatives is essential for both your care and your baby’s long-term neurodevelopmental health. CLINICAL OVERVIEW: Emerging research is exploring how prenatal cannabis exposure may alter genetic markers in the placenta, particularly in pregnancies associated with low birth weight, and whether those placental changes could serve as early indicators of neurodevelopmental risk including schizophrenia. This builds on what we already know clinically about the endocannabinoid system’s critical role in fetal brain development and placental function.
Key Congressional Committee Set To Vote On Delaying Federal Hemp THC Ban Next Week
WHY IT MATTERS: If you currently rely on hemp-derived THC products for symptom management, this proposed one-year delay could preserve your access to those products in the near term, but the uncertainty means you should discuss backup treatment plans with your clinician now. CLINICAL OVERVIEW: Congressional action to delay a federal ban on hemp-derived THC products reflects the ongoing tension between rapidly expanding consumer access and the lack of regulatory frameworks to ensure product safety, accurate labeling, and appropriate dosing. From a clinical standpoint, a one-year delay could preserve current patient access to hemp-derived cannabinoid products while ideally providing time for meaningful safety standards to be developed.